Risk Reduction for Alzheimer's Disease

NCT02913664 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

513

Enrollment

OTHER

Sponsor class

Conditions

Cognitively Normal Older Adults
Hypertension
Subjective Cognitive Decline
Family History of Alzheimer's Disease

Interventions

DRUG: Angiotensin II receptor blocker (ARB, losartan) and calcium channel blocker (CCB, amlodipine)
BEHAVIORAL: Aerobic Exercise Training
OTHER: Usual Care
BEHAVIORAL: Stretching Exercise

Sponsor

University of Texas Southwestern Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]